Establishment Labs (ESTA) Financials

$36.62 -0.23 (-0.62%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$36.63 +0.01 (+0.03%)

As of 05/23/2025 04:29 PM Eastern

Annual Income Statements for Establishment Labs

This table shows Establishment Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Net Income / (Loss) Attributable to Common Shareholders	-85	-79	-75	-41	-38	-38	-21	-35
Consolidated Net Income / (Loss)	-85	-79	-75	-41	-38	-38	-21	-35
Net Income / (Loss) Continuing Operations	-85	-79	-75	-41	-38	-38	-21	-35
Total Pre-Tax Income	-85	-79	-73	-40	-38	-38	-21	-35
Total Operating Income	-50	-65	-40	-25	-28	-31	-24	-20
Total Gross Profit	110	107	107	85	53	55	36	18
Total Revenue	166	165	162	127	85	90	61	35
Operating Revenue	166	165	162	127	85	90	61	35
Total Cost of Revenue	57	58	55	41	32	35	25	17
Operating Cost of Revenue	57	58	55	41	32	35	25	17
Total Operating Expenses	160	172	146	111	80	86	60	38
Selling, General & Admin Expense	140	146	126	92	67	71	47	31
Research & Development Expense	20	26	20	18	14	15	13	6.86
Total Other Income / (Expense), net	-35	-14	-33	-15	-10	-6.85	2.98	-15
Interest Expense	21	15	31	9.06	9.37	8.70	8.81	10
Interest & Investment Income	1.48	1.02	0.09	0.02	0.02	0.00	0.02	0.02
Other Income / (Expense), net	-15	0.82	-2.47	-5.53	-0.74	1.85	12	-4.41
Income Tax Expense	-0.03	-0.08	2.39	1.43	0.10	0.64	0.22	0.11
Basic Earnings per Share	($3.00)	($3.07)	($3.08)	($1.72)	($1.63)	($1.86)	($1.22)	($3.41)
Weighted Average Basic Shares Outstanding	28.16M	25.60M	24.46M	23.97M	23.32M	20.54M	17.35M	10.23M
Diluted Earnings per Share	($3.00)	($3.07)	($3.08)	($1.72)	($1.63)	($1.86)	($1.22)	($3.41)
Weighted Average Diluted Shares Outstanding	28.16M	25.60M	24.46M	23.97M	23.32M	20.54M	17.35M	10.23M
Weighted Average Basic & Diluted Shares Outstanding	28.85M	27.21M	24.42M	24.12M	23.32M	20.54M	17.35M	10.23M

This table shows Establishment Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-35	-17	-17	-16	-21	-29	-17	-12	-14	-19
Consolidated Net Income / (Loss)	-35	-17	-17	-16	-21	-29	-17	-12	-14	-19
Net Income / (Loss) Continuing Operations	-35	-17	-17	-16	-21	-29	-17	-12	-14	-19
Total Pre-Tax Income	-36	-16	-17	-16	-23	-29	-16	-11	-13	-18
Total Operating Income	-19	-13	-9.34	-8.83	-22	-21	-14	-8.16	-13	-11
Total Gross Profit	30	26	29	24	21	26	30	30	28	26
Total Revenue	45	40	44	37	32	39	49	47	44	38
Operating Revenue	45	40	44	37	32	39	49	47	44	38
Total Cost of Revenue	14	15	15	13	11	12	18	16	16	12
Operating Cost of Revenue	14	15	15	13	11	12	18	16	16	12
Total Operating Expenses	49	39	38	33	43	47	44	38	41	37
Selling, General & Admin Expense	44	34	33	29	37	40	37	32	35	31
Research & Development Expense	5.14	4.80	5.49	4.27	5.82	7.13	6.95	6.53	6.48	5.29
Total Other Income / (Expense), net	-17	-3.03	-7.41	-6.93	-0.93	-7.57	-2.11	-2.95	0.42	-7.49
Interest Expense	5.95	5.31	5.19	4.38	4.34	3.68	3.62	3.76	2.20	3.88
Interest & Investment Income	0.20	0.23	0.56	0.49	0.50	0.27	0.17	0.08	0.03	0.01
Other Income / (Expense), net	-12	2.05	-2.78	-3.04	2.90	-4.16	1.34	0.73	2.59	-3.62
Income Tax Expense	-1.41	0.51	0.43	0.44	-2.51	0.67	0.93	0.83	0.82	0.60
Basic Earnings per Share	($1.21)	($0.59)	($0.62)	($0.58)	($0.82)	($1.12)	($0.65)	($0.48)	($0.56)	($0.76)
Weighted Average Basic Shares Outstanding	28.16M	28.25M	27.91M	27.79M	25.60M	26.03M	25.62M	24.68M	24.46M	24.51M
Diluted Earnings per Share	($1.21)	($0.59)	($0.62)	($0.58)	($0.82)	($1.12)	($0.65)	($0.48)	($0.56)	($0.76)
Weighted Average Diluted Shares Outstanding	28.16M	28.25M	27.91M	27.79M	25.60M	26.03M	25.62M	24.68M	24.46M	24.51M
Weighted Average Basic & Diluted Shares Outstanding	28.85M	28.00M	27.94M	27.51M	27.21M	25.81M	25.78M	25.74M	24.42M	24.34M

This table details how cash moves in and out of Establishment Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Net Change in Cash & Equivalents	50	-26	13	-31	47	-15	42	10
Net Cash From Operating Activities	-59	-89	-52	-28	-13	-30	-34	-32
Net Cash From Continuing Operating Activities	-59	-89	-52	-28	-13	-30	-34	-32
Net Income / (Loss) Continuing Operations	-85	-79	-75	-41	-38	-38	-21	-35
Consolidated Net Income / (Loss)	-85	-79	-75	-41	-38	-38	-21	-35
Depreciation Expense	6.83	4.17	3.87	3.72	3.35	3.29	2.81	1.94
Amortization Expense	7.11	14	8.59	2.48	2.05	2.43	3.32	7.05
Non-Cash Adjustments To Reconcile Net Income	29	8.97	32	14	9.51	10	9.27	5.83
Changes in Operating Assets and Liabilities, net	-17	-37	-22	-6.76	11	-7.93	-28	-12
Net Cash From Investing Activities	-16	-25	-35	-7.16	-5.56	-7.77	-5.73	-0.85
Net Cash From Continuing Investing Activities	-16	-25	-35	-7.16	-5.56	-7.77	-5.73	-0.85
Purchase of Property, Plant & Equipment	-8.53	-23	-33	-5.28	-2.42	-6.29	-1.73	-0.90
Acquisitions	-7.08	-1.33	-2.02	-1.88	-3.14	-1.48	-4.00	-0.04
Net Cash From Financing Activities	126	86	100	4.05	65	23	82	43
Net Cash From Continuing Financing Activities	126	86	100	4.05	65	23	82	43
Repayment of Debt	0.00	0.00	-72	0.00	-0.28	-0.24	-5.39	-16
Issuance of Debt	24	0.00	168	0.00	0.00	25	0.00	39
Issuance of Common Equity	99	85	0.00	0.00	64	0.00	88	28
Other Financing Activities, net	1.94	1.69	3.87	4.05	1.09	0.54	-0.70	0.00
Effect of Exchange Rate Changes	-1.46	0.51	-0.36	-0.47	0.27	-0.02	-0.14	0.21
Cash Interest Paid	9.81	5.69	5.36	6.93	6.96	5.95	5.38	2.86
Cash Income Taxes Paid	1.74	2.17	2.13	0.65	0.32	0.65	0.14	0.15

This table details how cash moves in and out of Establishment Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	51	-15	-18	33	-12	-38	47	-24	-1.69	-23
Net Cash From Operating Activities	-21	-12	-14	-11	-8.15	-32	-28	-21	-14	-22
Net Cash From Continuing Operating Activities	-21	-12	-14	-11	-8.15	-32	-28	-21	-16	-20
Net Income / (Loss) Continuing Operations	-35	-17	-17	-16	-21	-29	-17	-12	-14	-19
Consolidated Net Income / (Loss)	-35	-17	-17	-16	-21	-29	-17	-12	-14	-19
Depreciation Expense	2.15	1.99	1.42	1.27	1.22	1.06	0.95	0.94	0.99	0.98
Amortization Expense	0.99	0.83	1.71	3.59	3.59	3.53	3.50	3.36	2.93	2.84
Non-Cash Adjustments To Reconcile Net Income	15	2.36	6.16	5.76	0.47	6.50	1.52	0.49	-4.34	7.14
Changes in Operating Assets and Liabilities, net	-4.25	-0.96	-6.26	-5.57	7.11	-13	-17	-13	-1.90	-12
Net Cash From Investing Activities	-1.82	-2.77	-4.40	-6.63	-4.62	-6.60	-9.05	-4.28	-10	-4.81
Net Cash From Continuing Investing Activities	-1.82	-2.77	-4.40	-6.63	-4.62	-6.60	-9.05	-4.28	-10	-4.81
Purchase of Property, Plant & Equipment	-0.62	-1.63	-1.53	-4.75	-3.66	-6.36	-8.97	-4.23	-10	-4.26
Acquisitions	-1.20	-1.13	-2.87	-1.88	-0.96	-0.24	-0.08	-0.05	-0.28	-0.55
Net Cash From Financing Activities	74	-0.03	0.39	51	0.07	0.49	84	1.18	25	1.27
Net Cash From Continuing Financing Activities	74	-0.03	0.39	51	0.07	0.49	84	1.18	25	1.27
Issuance of Common Equity	50	-	-	50	-	-	85	0.00	-	-
Other Financing Activities, net	0.28	-0.03	0.39	1.31	0.07	0.49	-0.07	1.21	0.50	1.27
Effect of Exchange Rate Changes	-1.27	0.35	-0.21	-0.32	0.55	-0.37	0.13	0.20	-	-
Cash Interest Paid	4.69	3.63	0.03	1.47	1.49	1.42	1.42	1.36	1.18	1.17
Cash Income Taxes Paid	0.92	0.07	0.07	0.68	0.36	0.81	0.78	0.22	0.83	0.45

This table presents Establishment Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Total Assets	347	269	211	140	156	117	117	57
Total Current Assets	243	175	150	113	132	96	99	39
Cash & Equivalents	90	40	66	53	85	38	53	11
Accounts Receivable	65	47	35	24	19	23	18	13
Inventories, net	79	79	37	28	23	29	25	13
Prepaid Expenses	8.92	8.48	12	7.01	5.44	6.76	4.30	2.24
Plant, Property, & Equipment, net	78	77	51	19	16	16	13	14
Total Noncurrent Assets	26	17	10	7.60	7.89	4.27	4.23	4.21
Goodwill	1.21	0.47	0.47	0.47	0.47	0.47	0.47	0.47
Intangible Assets	12	7.99	4.61	4.37	4.15	3.44	3.45	3.40
Other Noncurrent Operating Assets	13	8.08	4.99	2.76	3.27	0.37	0.32	0.35
Total Liabilities & Shareholders' Equity	347	269	211	140	156	117	117	57
Total Liabilities	294	250	219	89	81	77	47	62
Total Current Liabilities	68	57	39	32	26	23	16	57
Accounts Payable	45	42	20	14	9.72	10	6.24	9.13
Accrued Expenses	17	14	17	16	15	11	6.13	2.33
Other Current Liabilities	6.98	1.84	1.69	1.18	1.65	2.20	4.08	46
Total Noncurrent Liabilities	225	193	180	57	56	54	31	4.67
Long-Term Debt	220	189	175	52	50	48	22	0.00
Other Noncurrent Operating Liabilities	5.88	4.36	4.83	5.00	5.70	5.53	8.32	4.67
Commitments & Contingencies	0.00	0.00	0.00	0.00	-	0.00	-	-
Total Equity & Noncontrolling Interests	53	18	-8.19	51	75	40	69	-5.01
Total Preferred & Common Equity	53	18	-8.19	51	75	40	69	-5.01
Total Common Equity	53	18	-8.19	51	75	40	69	-5.01
Common Stock	497	379	274	256	240	169	161	69
Retained Earnings	-445	-360	-282	-206	-165	-127	-89	-68
Treasury Stock	-2.85	-2.85	-	-2.85	-2.85	-2.85	-2.85	-6.47
Accumulated Other Comprehensive Income / (Loss)	3.29	1.96	2.72	3.66	2.87	0.69	0.45	0.08

This table presents Establishment Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	283	285	302	271	285	209	188
Total Current Assets	183	186	204	187	209	142	138
Cash & Equivalents	40	55	73	52	90	43	65
Accounts Receivable	67	60	51	55	51	41	31
Inventories, net	67	64	72	68	56	46	32
Prepaid Expenses	8.88	7.34	7.39	12	11	12	10
Plant, Property, & Equipment, net	79	80	79	73	66	57	39
Total Noncurrent Assets	20	19	19	11	10	10	10
Goodwill	0.47	0.47	0.47	0.47	0.47	0.47	0.47
Intangible Assets	9.78	10	9.52	5.71	4.23	4.37	4.63
Other Noncurrent Operating Assets	10	8.90	8.92	5.00	5.38	5.44	5.18
Total Liabilities & Shareholders' Equity	283	285	302	271	285	209	188
Total Liabilities	250	240	245	240	230	225	186
Total Current Liabilities	50	42	48	50	43	41	32
Accounts Payable	34	28	31	29	24	20	15
Accrued Expenses	14	12	15	19	17	20	17
Current Deferred Revenue	1.65	-	-	-	-	-	-
Other Current Liabilities	2.28	1.66	1.74	1.99	1.48	1.58	0.79
Total Noncurrent Liabilities	199	198	197	190	187	184	154
Long-Term Debt	194	194	192	185	182	179	148
Other Noncurrent Operating Liabilities	5.12	4.45	4.73	4.42	5.18	5.24	5.57
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	33	45	57	30	55	-16	1.52
Total Preferred & Common Equity	33	45	57	30	55	-16	1.52
Total Common Equity	33	45	57	30	55	-16	1.52
Common Stock	442	438	434	371	366	278	270
Retained Earnings	-410	-393	-376	-340	-310	-294	-268
Treasury Stock	-2.85	-2.85	-2.85	-2.85	-2.85	-	-2.85
Accumulated Other Comprehensive Income / (Loss)	3.23	3.12	2.08	1.95	1.81	2.31	2.60

This table displays calculated financial ratios and metrics derived from Establishment Labs' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	0.53%	2.13%	27.64%	49.61%	-5.46%	46.33%	76.49%	0.00%
EBITDA Growth	-11.46%	-55.21%	-21.22%	-5.23%	0.51%	-292.38%	61.31%	0.00%
EBIT Growth	-1.66%	-52.40%	-37.36%	-7.03%	1.50%	-140.74%	50.45%	0.00%
NOPAT Growth	23.13%	-63.97%	-57.75%	9.94%	9.78%	-29.66%	-19.42%	0.00%
Net Income Growth	-7.76%	-4.38%	-82.82%	-7.92%	0.08%	-80.82%	39.54%	0.00%
EPS Growth	2.28%	0.32%	-79.07%	-5.52%	12.37%	-52.46%	64.22%	0.00%
Operating Cash Flow Growth	33.89%	-69.68%	-89.47%	-120.08%	58.28%	11.52%	-5.99%	0.00%
Free Cash Flow Firm Growth	55.04%	-40.58%	-199.16%	-173.51%	70.21%	54.58%	0.00%	0.00%
Invested Capital Growth	9.11%	65.57%	105.00%	22.25%	-19.62%	27.91%	346.70%	0.00%
Revenue Q/Q Growth	8.46%	-6.91%	5.55%	7.06%	3.31%	9.61%	0.00%	0.00%
EBITDA Q/Q Growth	-32.70%	-18.05%	8.58%	-39.34%	-2.36%	16.16%	0.00%	0.00%
EBIT Q/Q Growth	-20.21%	-14.11%	1.08%	-30.05%	-1.77%	13.81%	0.00%	0.00%
NOPAT Q/Q Growth	6.45%	-15.97%	-10.58%	-5.67%	-14.86%	11.99%	0.00%	0.00%
Net Income Q/Q Growth	-19.81%	-9.76%	0.83%	-26.20%	-0.25%	11.50%	0.00%	0.00%
EPS Q/Q Growth	-14.94%	-9.25%	1.28%	-29.32%	3.55%	10.14%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-27.44%	6.22%	-13.75%	-67.99%	37.36%	12.93%	-1.01%	0.00%
Free Cash Flow Firm Q/Q Growth	15.61%	5.75%	-29.85%	-55.91%	38.92%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	-1.83%	2.13%	19.63%	1.97%	-15.93%	2.22%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	65.97%	64.78%	65.92%	67.42%	62.00%	61.25%	59.01%	51.04%
EBITDA Margin	-30.92%	-27.88%	-18.35%	-19.32%	-27.47%	-26.10%	-9.73%	-44.40%
Operating Margin	-30.11%	-39.37%	-24.53%	-19.85%	-32.97%	-34.55%	-38.99%	-57.62%
EBIT Margin	-39.32%	-38.88%	-26.06%	-24.21%	-33.85%	-32.48%	-19.74%	-70.33%
Profit (Net Income) Margin	-50.95%	-47.53%	-46.51%	-32.47%	-45.02%	-42.59%	-34.47%	-100.62%
Tax Burden Percent	99.96%	99.90%	103.28%	103.59%	100.27%	101.71%	101.03%	100.30%
Interest Burden Percent	129.65%	122.38%	172.85%	129.47%	132.65%	128.93%	172.80%	142.64%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-20.03%	-33.97%	-36.98%	-39.33%	-43.25%	-48.52%	-143.44%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-55.72%	-59.55%	-125.17%	90.74%	110.28%	117.80%	-122.11%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-216.64%	-1,503.78%	-316.50%	-26.13%	-23.30%	-21.41%	78.00%	0.00%
Return on Equity (ROE)	-236.67%	-1,537.75%	-353.48%	-65.46%	-66.54%	-69.94%	-65.45%	696.13%
Cash Return on Invested Capital (CROIC)	-28.74%	-83.35%	-105.83%	-59.35%	-21.49%	-73.02%	-183.18%	0.00%
Operating Return on Assets (OROA)	-21.21%	-26.77%	-24.03%	-20.73%	-21.00%	-24.96%	-13.92%	-42.72%
Return on Assets (ROA)	-27.49%	-32.73%	-42.90%	-27.80%	-27.94%	-32.73%	-24.30%	-61.12%
Return on Common Equity (ROCE)	-236.67%	-1,537.75%	-353.48%	-65.46%	-66.54%	-69.94%	-65.45%	696.13%
Return on Equity Simple (ROE_SIMPLE)	-159.33%	-426.76%	918.86%	-81.08%	-50.85%	-96.30%	-30.36%	696.13%
Net Operating Profit after Tax (NOPAT)	-35	-46	-28	-18	-20	-22	-17	-14
NOPAT Margin	-21.08%	-27.56%	-17.17%	-13.89%	-23.08%	-24.18%	-27.29%	-40.33%
Net Nonoperating Expense Percent (NNEP)	35.70%	25.59%	88.20%	-130.06%	-153.53%	-166.33%	-21.34%	-192.46%
Return On Investment Capital (ROIC_SIMPLE)	-12.83%	-21.98%	-16.60%	-	-	-	-	-
Cost of Revenue to Revenue	34.03%	35.22%	34.08%	32.58%	38.00%	38.75%	40.99%	48.96%
SG&A Expenses to Revenue	84.21%	88.15%	77.91%	72.80%	78.68%	79.06%	77.27%	88.87%
R&D to Revenue	11.87%	16.00%	12.53%	14.46%	16.29%	16.74%	20.73%	19.79%
Operating Expenses to Revenue	96.08%	104.15%	90.45%	87.26%	94.97%	95.49%	98.00%	108.66%
Earnings before Interest and Taxes (EBIT)	-65	-64	-42	-31	-29	-29	-12	-24
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-51	-46	-30	-24	-23	-23	-5.96	-15
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	24.29	36.32	0.00	31.98	11.77	14.38	8.10	0.00
Price to Tangible Book Value (P/TBV)	32.08	67.20	0.00	35.34	12.54	15.96	8.59	0.00
Price to Revenue (P/Rev)	7.77	4.05	9.88	12.81	10.42	6.36	9.20	1.93
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	7.78	4.89	16.92	32.93	21.05	11.58	13.60	0.00
Enterprise Value to Revenue (EV/Rev)	8.55	4.95	10.56	12.80	10.01	6.48	8.71	1.62
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	4.14	10.26	-21.44	1.02	0.66	1.22	0.32	0.00
Long-Term Debt to Equity	4.14	10.26	-21.44	1.02	0.66	1.22	0.32	0.00
Financial Leverage	3.89	25.25	2.53	-0.29	-0.21	-0.18	-0.64	2.17
Leverage Ratio	8.61	46.98	8.24	2.35	2.38	2.14	2.69	-11.39
Compound Leverage Factor	11.16	57.50	14.24	3.05	3.16	2.75	4.65	-16.25
Debt to Total Capital	80.53%	91.12%	104.89%	50.57%	39.93%	54.86%	24.31%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	80.53%	91.12%	104.89%	50.57%	39.93%	54.86%	24.31%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	19.47%	8.88%	-4.89%	49.43%	60.07%	45.14%	75.69%	100.00%
Debt to EBITDA	-4.28	-4.10	-5.91	-2.12	-2.14	-2.06	-3.75	0.00
Net Debt to EBITDA	-2.52	-3.23	-3.68	0.06	1.49	-0.45	5.09	0.00
Long-Term Debt to EBITDA	-4.28	-4.10	-5.91	-2.12	-2.14	-2.06	-3.75	0.00
Debt to NOPAT	-6.28	-4.15	-6.32	-2.95	-2.55	-2.22	-1.34	0.00
Net Debt to NOPAT	-3.69	-3.27	-3.93	0.09	1.78	-0.48	1.81	0.00
Long-Term Debt to NOPAT	-6.28	-4.15	-6.32	-2.95	-2.55	-2.22	-1.34	0.00
Altman Z-Score	1.30	0.08	3.24	9.78	5.77	3.61	7.14	-2.20
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	3.56	3.06	3.85	3.55	5.11	4.12	6.05	0.69
Quick Ratio	2.28	1.52	2.61	2.44	4.00	2.60	4.27	0.42
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-50	-112	-79	-27	-9.71	-33	-72	0.00
Operating Cash Flow to CapEx	-686.16%	-381.21%	-159.16%	-521.24%	-516.30%	-476.83%	-1,957.54%	-3,548.28%
Free Cash Flow to Firm to Interest Expense	-2.41	-7.26	-2.58	-2.93	-1.04	-3.75	-8.14	0.00
Operating Cash Flow to Interest Expense	-2.81	-5.75	-1.69	-3.04	-1.33	-3.45	-3.84	-3.07
Operating Cash Flow Less CapEx to Interest Expense	-3.22	-7.26	-2.76	-3.62	-1.59	-4.17	-4.04	-3.15
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.54	0.69	0.92	0.86	0.62	0.77	0.70	0.61
Accounts Receivable Turnover	2.97	4.01	5.40	5.82	4.04	4.43	3.98	2.65
Inventory Turnover	0.71	1.00	1.70	1.60	1.24	1.30	1.32	1.29
Fixed Asset Turnover	2.14	2.57	4.64	7.27	5.19	6.11	4.63	2.57
Accounts Payable Turnover	1.31	1.89	3.19	3.41	3.20	4.18	3.26	1.86
Days Sales Outstanding (DSO)	123.03	90.99	67.56	62.76	90.29	82.35	91.70	137.96
Days Inventory Outstanding (DIO)	511.12	364.08	215.24	228.21	294.22	281.37	276.54	283.18
Days Payable Outstanding (DPO)	279.03	193.43	114.29	106.98	113.94	87.32	111.80	196.29
Cash Conversion Cycle (CCC)	355.12	261.64	168.51	183.99	270.57	276.40	256.44	224.85
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	182	167	101	49	40	50	39	-16
Invested Capital Turnover	0.95	1.23	2.15	2.83	1.87	2.01	5.26	-2.18
Increase / (Decrease) in Invested Capital	15	66	52	8.96	-9.83	11	55	0.00
Enterprise Value (EV)	1,419	817	1,707	1,621	848	580	533	56
Market Capitalization	1,290	668	1,598	1,622	882	570	563	67
Book Value per Share	$1.90	$0.71	($0.34)	$2.11	$3.20	$1.92	$3.38	($0.49)
Tangible Book Value per Share	$1.44	$0.39	($0.54)	$1.91	$3.00	$1.73	$3.19	($0.87)
Total Capital	273	207	167	103	125	88	92	-5.01
Total Debt	220	189	175	52	50	48	22	0.00
Total Long-Term Debt	220	189	175	52	50	48	22	0.00
Net Debt	129	149	109	-1.51	-35	10	-30	-11
Capital Expenditures (CapEx)	8.53	23	33	5.28	2.42	6.29	1.73	0.90
Debt-free, Cash-free Net Working Capital (DFCFNWC)	84	78	45	28	22	35	30	-29
Debt-free Net Working Capital (DFNWC)	175	118	111	81	106	73	83	-18
Net Working Capital (NWC)	175	118	111	81	106	73	83	-18
Net Nonoperating Expense (NNE)	50	33	47	24	19	16	4.39	21
Net Nonoperating Obligations (NNO)	129	149	109	-1.51	-35	10	-30	-11
Total Depreciation and Amortization (D&A)	14	18	12	6.20	5.40	5.72	6.13	8.99
Debt-free, Cash-free Net Working Capital to Revenue	50.84%	47.06%	27.58%	22.08%	25.83%	39.01%	49.58%	-83.38%
Debt-free Net Working Capital to Revenue	105.26%	71.30%	68.61%	64.24%	125.65%	81.06%	135.58%	-52.05%
Net Working Capital to Revenue	105.26%	71.30%	68.61%	64.24%	125.65%	81.06%	135.58%	-52.05%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($3.00)	($3.07)	($3.08)	($1.72)	($1.63)	($1.86)	($1.22)	($3.41)
Adjusted Weighted Average Basic Shares Outstanding	28.16M	25.60M	24.46M	23.97M	23.55M	23.33M	20.39M	10.23M
Adjusted Diluted Earnings per Share	($3.00)	($3.07)	($3.08)	($1.72)	($1.63)	($1.86)	($1.22)	($3.41)
Adjusted Weighted Average Diluted Shares Outstanding	28.16M	25.60M	24.46M	23.97M	23.55M	23.33M	20.39M	10.23M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	($1.63)	($1.86)	($1.22)	($3.41)
Adjusted Weighted Average Basic & Diluted Shares Outstanding	28.85M	27.21M	24.42M	24.12M	23.32M	20.54M	17.35M	10.23M
Normalized Net Operating Profit after Tax (NOPAT)	-35	-46	-28	-18	-20	-22	-17	-14
Normalized NOPAT Margin	-21.08%	-27.56%	-17.17%	-13.89%	-23.08%	-24.40%	-27.29%	-40.33%
Pre Tax Income Margin	-50.97%	-47.58%	-45.04%	-31.35%	-44.90%	-41.88%	-34.12%	-100.32%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-3.13	-4.17	-1.37	-3.38	-3.06	-3.35	-1.37	-2.34
NOPAT to Interest Expense	-1.68	-2.96	-0.90	-1.94	-2.08	-2.49	-1.90	-1.34
EBIT Less CapEx to Interest Expense	-3.54	-5.68	-2.43	-3.97	-3.32	-4.07	-1.57	-2.43
NOPAT Less CapEx to Interest Expense	-2.09	-4.47	-1.97	-2.52	-2.34	-3.21	-2.09	-1.43
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	-5.93%	0.00%	-22.41%

This table displays calculated financial ratios and metrics derived from Establishment Labs' official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	41.05%	4.47%	-9.15%	-20.11%	-27.97%	0.68%	17.90%	20.99%	24.07%	31.70%
EBITDA Growth	-87.85%	59.83%	-13.57%	-123.92%	-116.41%	-99.58%	28.40%	-91.62%	29.52%	4.43%
EBIT Growth	-57.13%	55.97%	2.00%	-59.75%	-81.80%	-78.25%	12.68%	-127.81%	4.17%	-14.15%
NOPAT Growth	15.58%	37.55%	31.86%	-8.26%	-68.05%	-100.04%	-31.78%	-46.37%	-40.51%	-16.29%
Net Income Growth	-68.10%	43.01%	-2.60%	-35.67%	-51.47%	-57.31%	54.87%	-101.28%	4.43%	-26.77%
EPS Growth	-47.56%	47.32%	4.62%	-20.83%	-46.43%	-47.37%	57.24%	-100.00%	6.67%	-24.59%
Operating Cash Flow Growth	-154.65%	60.46%	49.88%	45.90%	41.87%	-43.36%	-149.25%	-325.91%	-81.81%	-76.48%
Free Cash Flow Firm Growth	65.35%	66.70%	48.90%	10.53%	-34.08%	-116.33%	-149.47%	-376.43%	-292.51%	-547.37%
Invested Capital Growth	9.11%	13.51%	25.56%	47.00%	65.57%	93.95%	109.25%	115.23%	105.00%	74.73%
Revenue Q/Q Growth	10.66%	-8.82%	18.70%	17.77%	-18.04%	-20.71%	4.38%	6.19%	14.56%	-7.15%
EBITDA Q/Q Growth	-226.81%	7.98%	-28.28%	51.31%	30.11%	-160.15%	-152.92%	57.44%	35.55%	6.67%
EBIT Q/Q Growth	-172.14%	8.50%	-2.12%	38.21%	23.75%	-103.69%	-66.46%	34.07%	25.24%	0.23%
NOPAT Q/Q Growth	-42.10%	-40.61%	-5.77%	60.05%	-5.12%	-53.42%	-68.05%	37.99%	-25.13%	-1.07%
Net Income Q/Q Growth	-107.00%	2.90%	-6.04%	21.13%	29.83%	-74.82%	-40.22%	11.95%	27.12%	49.85%
EPS Q/Q Growth	-105.08%	4.84%	-6.90%	29.27%	26.79%	-72.31%	-35.42%	14.29%	26.32%	50.00%
Operating Cash Flow Q/Q Growth	-66.51%	11.96%	-26.92%	-36.87%	74.14%	-11.58%	-36.99%	-47.07%	36.23%	-94.00%
Free Cash Flow Firm Q/Q Growth	9.60%	28.92%	29.55%	23.47%	13.11%	-9.07%	-23.36%	-14.69%	-40.19%	-25.77%
Invested Capital Q/Q Growth	-1.83%	0.85%	4.56%	5.40%	2.13%	11.56%	22.42%	18.71%	19.63%	20.36%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	68.50%	63.93%	65.59%	65.60%	65.23%	67.66%	62.32%	64.65%	64.28%	68.09%
EBITDA Margin	-60.76%	-20.57%	-20.39%	-18.86%	-45.62%	-53.50%	-16.31%	-6.73%	-15.19%	-26.99%
Operating Margin	-41.94%	-32.66%	-21.18%	-23.77%	-70.07%	-54.64%	-28.24%	-17.54%	-30.04%	-27.50%
EBIT Margin	-67.82%	-27.58%	-27.48%	-31.94%	-60.88%	-65.43%	-25.47%	-15.97%	-24.12%	-36.96%
Profit (Net Income) Margin	-77.57%	-41.47%	-38.94%	-43.59%	-65.09%	-76.02%	-34.48%	-25.67%	-30.95%	-48.65%
Tax Burden Percent	96.08%	103.15%	102.55%	102.78%	89.13%	102.34%	105.85%	107.47%	106.43%	103.35%
Interest Burden Percent	119.05%	145.79%	138.19%	132.79%	119.96%	113.53%	127.89%	149.54%	120.58%	127.38%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-27.90%	-20.04%	-13.57%	-17.52%	-60.45%	-54.72%	-32.31%	-23.76%	-45.29%	-44.47%
ROIC Less NNEP Spread (ROIC-NNEP)	-43.34%	-25.27%	-22.78%	-25.38%	-64.38%	-68.19%	-42.10%	-32.43%	-53.37%	-76.80%
Return on Net Nonoperating Assets (RNNOA)	-168.51%	-114.41%	-52.66%	-158.16%	-1,625.54%	-460.15%	-86.89%	-146.31%	-134.95%	-84.69%
Return on Equity (ROE)	-196.41%	-134.44%	-66.23%	-175.68%	-1,685.99%	-514.87%	-119.20%	-170.07%	-180.24%	-129.16%
Cash Return on Invested Capital (CROIC)	-28.74%	-34.07%	-48.62%	-69.14%	-83.35%	-95.58%	-100.07%	-106.81%	-105.83%	-92.26%
Operating Return on Assets (OROA)	-36.59%	-15.26%	-14.58%	-19.47%	-41.92%	-50.67%	-18.60%	-15.45%	-22.25%	-33.70%
Return on Assets (ROA)	-41.85%	-22.95%	-20.67%	-26.57%	-44.82%	-58.87%	-25.18%	-24.84%	-28.55%	-44.37%
Return on Common Equity (ROCE)	-196.41%	-134.44%	-66.23%	-175.68%	-1,685.99%	-514.87%	-119.20%	-170.07%	-180.24%	-129.16%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-215.86%	-184.81%	-145.42%	0.00%	-234.60%	-110.91%	507.74%	0.00%	-4,992.63%
Net Operating Profit after Tax (NOPAT)	-13	-9.20	-6.54	-6.18	-15	-15	-9.60	-5.71	-9.21	-7.36
NOPAT Margin	-29.36%	-22.86%	-14.83%	-16.64%	-49.05%	-38.24%	-19.77%	-12.28%	-21.03%	-19.25%
Net Nonoperating Expense Percent (NNEP)	15.44%	5.23%	9.22%	7.86%	3.93%	13.47%	9.79%	8.68%	8.09%	32.33%
Return On Investment Capital (ROIC_SIMPLE)	-4.79%	-	-	-	-7.47%	-	-	-	-5.51%	-
Cost of Revenue to Revenue	31.50%	36.07%	34.41%	34.40%	34.78%	32.34%	37.68%	35.35%	35.72%	31.91%
SG&A Expenses to Revenue	98.89%	84.66%	74.33%	77.87%	116.86%	103.78%	76.25%	68.15%	79.53%	81.76%
R&D to Revenue	11.56%	11.93%	12.44%	11.50%	18.44%	18.51%	14.31%	14.04%	14.79%	13.83%
Operating Expenses to Revenue	110.44%	96.59%	86.77%	89.36%	135.30%	122.29%	90.55%	82.19%	94.32%	95.59%
Earnings before Interest and Taxes (EBIT)	-30	-11	-12	-12	-19	-25	-12	-7.43	-11	-14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-27	-8.28	-8.99	-7.01	-14	-21	-7.92	-3.13	-6.65	-10
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	24.29	36.96	27.77	24.33	36.32	41.49	32.18	0.00	0.00	872.48
Price to Tangible Book Value (P/TBV)	32.08	53.83	36.23	29.51	67.20	52.01	35.19	0.00	0.00	0.00
Price to Revenue (P/Rev)	7.77	7.90	8.26	8.89	4.05	7.13	9.97	9.74	9.88	8.65
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	7.78	7.34	7.54	8.54	4.89	8.54	12.67	14.94	16.92	16.69
Enterprise Value to Revenue (EV/Rev)	8.55	8.91	9.18	9.65	4.95	7.88	10.49	10.54	10.56	9.19
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	4.14	5.94	4.30	3.38	10.26	6.08	3.32	-11.17	-21.44	97.56
Long-Term Debt to Equity	4.14	5.94	4.30	3.38	10.26	6.08	3.32	-11.17	-21.44	97.56
Financial Leverage	3.89	4.53	2.31	6.23	25.25	6.75	2.06	4.51	2.53	1.10
Leverage Ratio	8.61	8.75	5.71	12.49	46.98	14.32	6.86	11.02	8.24	5.33
Compound Leverage Factor	10.25	12.76	7.89	16.59	56.36	16.25	8.77	16.48	9.93	6.79
Debt to Total Capital	80.53%	85.59%	81.14%	77.15%	91.12%	85.87%	76.83%	109.83%	104.89%	98.99%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	80.53%	85.59%	81.14%	77.15%	91.12%	85.87%	76.83%	109.83%	104.89%	98.99%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	19.47%	14.41%	18.86%	22.85%	8.88%	14.13%	23.17%	-9.83%	-4.89%	1.01%
Debt to EBITDA	-4.28	-5.02	-3.80	-3.85	-4.10	-4.75	-6.33	-5.61	-5.91	-4.57
Net Debt to EBITDA	-2.52	-4.00	-2.73	-2.39	-3.23	-3.41	-3.20	-4.26	-3.68	-2.55
Long-Term Debt to EBITDA	-4.28	-5.02	-3.80	-3.85	-4.10	-4.75	-6.33	-5.61	-5.91	-4.57
Debt to NOPAT	-6.28	-5.20	-4.51	-4.18	-4.15	-4.72	-5.71	-6.04	-6.32	-5.90
Net Debt to NOPAT	-3.69	-4.14	-3.24	-2.59	-3.27	-3.39	-2.88	-4.59	-3.93	-3.30
Long-Term Debt to NOPAT	-6.28	-5.20	-4.51	-4.18	-4.15	-4.72	-5.71	-6.04	-6.32	-5.90
Altman Z-Score	1.64	1.85	2.19	2.65	0.63	2.36	4.25	3.71	3.74	3.52
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.56	3.62	4.44	4.24	3.06	3.71	4.83	3.43	3.85	4.27
Quick Ratio	2.28	2.12	2.74	2.58	1.52	2.12	3.27	2.02	2.61	2.98
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-28	-31	-44	-62	-82	-94	-86	-70	-61	-43
Operating Cash Flow to CapEx	-3,352.02%	-763.07%	-925.70%	-234.93%	-222.50%	-495.77%	-314.76%	-487.44%	-138.14%	-516.33%
Free Cash Flow to Firm to Interest Expense	-4.76	-5.89	-8.49	-14.27	-18.82	-25.55	-23.80	-18.60	-27.68	-11.20
Operating Cash Flow to Interest Expense	-3.49	-2.35	-2.73	-2.55	-1.88	-8.57	-7.80	-5.49	-6.37	-5.66
Operating Cash Flow Less CapEx to Interest Expense	-3.59	-2.65	-3.02	-3.63	-2.72	-10.29	-10.28	-6.61	-10.98	-6.76
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.54	0.55	0.53	0.61	0.69	0.77	0.73	0.97	0.92	0.91
Accounts Receivable Turnover	2.97	2.51	2.72	3.39	4.01	4.13	4.25	4.80	5.40	5.48
Inventory Turnover	0.71	0.79	0.85	0.92	1.00	1.26	1.51	1.55	1.70	1.74
Fixed Asset Turnover	2.14	2.01	2.08	2.29	2.57	3.17	3.49	4.23	4.64	5.47
Accounts Payable Turnover	1.31	1.69	1.95	2.12	1.89	2.87	3.10	3.15	3.19	4.02
Days Sales Outstanding (DSO)	123.03	145.39	134.30	107.64	90.99	88.41	85.92	76.04	67.56	66.65
Days Inventory Outstanding (DIO)	511.12	461.11	428.17	397.13	364.08	288.91	241.69	234.84	215.24	210.18
Days Payable Outstanding (DPO)	279.03	216.21	187.41	171.81	193.43	127.21	117.62	116.06	114.29	90.76
Cash Conversion Cycle (CCC)	355.12	390.30	375.06	332.95	261.64	250.11	209.99	194.83	168.51	186.07
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	182	186	184	176	167	164	147	120	101	84
Invested Capital Turnover	0.95	0.88	0.92	1.05	1.23	1.43	1.63	1.94	2.15	2.31
Increase / (Decrease) in Invested Capital	15	22	37	56	66	79	77	64	52	36
Enterprise Value (EV)	1,419	1,364	1,389	1,504	817	1,398	1,858	1,790	1,707	1,408
Market Capitalization	1,290	1,209	1,250	1,385	668	1,265	1,766	1,654	1,598	1,325
Book Value per Share	$1.90	$1.17	$1.64	$2.09	$0.71	$1.18	$2.13	($0.66)	($0.34)	$0.06
Tangible Book Value per Share	$1.44	$0.80	$1.25	$1.73	$0.39	$0.94	$1.95	($0.85)	($0.54)	($0.15)
Total Capital	273	227	239	249	207	216	237	163	167	150
Total Debt	220	194	194	192	189	185	182	179	175	148
Total Long-Term Debt	220	194	194	192	189	185	182	179	175	148
Net Debt	129	155	139	119	149	133	92	136	109	83
Capital Expenditures (CapEx)	0.62	1.63	1.53	4.75	3.66	6.36	8.97	4.23	10	4.26
Debt-free, Cash-free Net Working Capital (DFCFNWC)	84	93	90	83	78	84	76	58	45	40
Debt-free Net Working Capital (DFNWC)	175	132	144	156	118	136	166	101	111	106
Net Working Capital (NWC)	175	132	144	156	118	136	166	101	111	106
Net Nonoperating Expense (NNE)	21	7.48	11	10	5.06	15	7.15	6.23	4.35	11
Net Nonoperating Obligations (NNO)	129	153	139	119	149	133	92	136	109	83
Total Depreciation and Amortization (D&A)	3.14	2.82	3.13	4.86	4.82	4.60	4.45	4.30	3.92	3.81
Debt-free, Cash-free Net Working Capital to Revenue	50.84%	60.60%	59.23%	53.08%	47.06%	47.48%	42.66%	34.00%	27.58%	26.40%
Debt-free Net Working Capital to Revenue	105.26%	86.53%	95.30%	99.93%	71.30%	76.90%	93.57%	59.24%	68.61%	69.05%
Net Working Capital to Revenue	105.26%	86.53%	95.30%	99.93%	71.30%	76.90%	93.57%	59.24%	68.61%	69.05%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.21)	($0.59)	($0.62)	($0.58)	($0.82)	($1.12)	($0.65)	($0.48)	($0.56)	($0.76)
Adjusted Weighted Average Basic Shares Outstanding	28.16M	28.25M	27.91M	27.79M	25.60M	26.03M	25.62M	24.68M	24.46M	24.51M
Adjusted Diluted Earnings per Share	($1.21)	($0.59)	($0.62)	($0.58)	($0.82)	($1.12)	($0.65)	($0.48)	($0.56)	($0.76)
Adjusted Weighted Average Diluted Shares Outstanding	28.16M	28.25M	27.91M	27.79M	25.60M	26.03M	25.62M	24.68M	24.46M	24.51M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	28.85M	28.00M	27.94M	27.51M	27.21M	25.81M	25.78M	25.74M	24.42M	24.34M
Normalized Net Operating Profit after Tax (NOPAT)	-13	-9.20	-6.54	-6.18	-15	-15	-9.60	-5.71	-9.21	-7.36
Normalized NOPAT Margin	-29.36%	-22.86%	-14.83%	-16.64%	-49.05%	-38.24%	-19.77%	-12.28%	-21.03%	-19.25%
Pre Tax Income Margin	-80.74%	-40.20%	-37.97%	-42.41%	-73.03%	-74.28%	-32.58%	-23.88%	-29.09%	-47.08%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-5.07	-2.09	-2.34	-2.71	-4.43	-6.85	-3.42	-1.98	-4.80	-3.64
NOPAT to Interest Expense	-2.20	-1.73	-1.26	-1.41	-3.57	-4.00	-2.65	-1.52	-4.19	-1.90
EBIT Less CapEx to Interest Expense	-5.18	-2.40	-2.63	-3.79	-5.27	-8.58	-5.90	-3.10	-9.42	-4.74
NOPAT Less CapEx to Interest Expense	-2.30	-2.04	-1.56	-2.50	-4.41	-5.73	-5.13	-2.65	-8.80	-2.99
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Establishment Labs' Financials

When does Establishment Labs's fiscal year end?

According to the most recent income statement we have on file, Establishment Labs' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Establishment Labs' net income changed over the last 7 years?

Establishment Labs' net income appears to be on an upward trend, with a most recent value of -$84.60 million in 2024, rising from -$34.90 million in 2017. The previous period was -$78.50 million in 2023. See Establishment Labs' forecast for analyst expectations on what’s next for the company.

What is Establishment Labs's operating income?

Establishment Labs's total operating income in 2024 was -$49.99 million, based on the following breakdown:

Total Gross Profit: $109.53 million
Total Operating Expenses: $159.51 million

How has Establishment Labs revenue changed over the last 7 years?

Over the last 7 years, Establishment Labs' total revenue changed from $34.68 million in 2017 to $166.03 million in 2024, a change of 378.7%.

How much debt does Establishment Labs have?

Establishment Labs' total liabilities were at $293.74 million at the end of 2024, a 17.4% increase from 2023, and a 372.9% increase since 2017.

How much cash does Establishment Labs have?

In the past 7 years, Establishment Labs' cash and equivalents has ranged from $10.86 million in 2017 to $90.35 million in 2024, and is currently $90.35 million as of their latest financial filing in 2024.

How has Establishment Labs' book value per share changed over the last 7 years?

Over the last 7 years, Establishment Labs' book value per share changed from -0.49 in 2017 to 1.90 in 2024, a change of -487.0%.

Related Companies

This page (NASDAQ:ESTA) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Establishment Labs (ESTA) Financials

Frequently Asked Questions About Establishment Labs' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Establishment Labs (ESTA) Financials

Annual Income Statements for Establishment Labs

Quarterly Income Statements for Establishment Labs

Annual Cash Flow Statements for Establishment Labs

Quarterly Cash Flow Statements for Establishment Labs

Annual Balance Sheets for Establishment Labs

Quarterly Balance Sheets for Establishment Labs

Annual Metrics And Ratios for Establishment Labs

Quarterly Metrics And Ratios for Establishment Labs

Frequently Asked Questions About Establishment Labs' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools